Ovid Therapeutics Inc (NASDAQ: OVID) open the trading on Thursday, with a bit cautious approach as it glided -9.09% to $1.2, before settling in for the price of $1.32 at the close. Taking a more long-term approach, OVID posted a 52-week range of $0.24-$2.01.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 24.72%. Meanwhile, its Annual Earning per share during the time was 24.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.39%. This publicly-traded company’s shares outstanding now amounts to $71.15 million, simultaneously with a float of $59.54 million. The organization now has a market capitalization sitting at $85.33 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4372, while the 200-day Moving Average is $0.7261.
Ovid Therapeutics Inc (OVID) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Ovid Therapeutics Inc’s current insider ownership accounts for 16.29%, in contrast to 33.50% institutional ownership. According to the most recent insider trade that took place on Feb 26 ’25, this organization’s President and COO sold 5,279 shares at the rate of 0.56, making the entire transaction reach 2,956 in total value, affecting insider ownership by 73,406. Preceding that transaction, on Feb 26 ’25, Company’s CBFO sold 3,902 for 0.56, making the whole transaction’s value amount to 2,185. This particular insider is now the holder of 67,973 in total.
Ovid Therapeutics Inc (OVID) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year. Ovid Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -29.39% and is forecasted to reach -0.44 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -14.40% through the next 5 years, which can be compared against the 24.72% growth it accomplished over the previous five years trading on the market.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Let’s observe the current performance indicators for Ovid Therapeutics Inc (OVID). It’s Quick Ratio in the last reported quarter now stands at 4.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 12.91.
In the same vein, OVID’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.51, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.44 at the market close of one year from today.
Technical Analysis of Ovid Therapeutics Inc (OVID)
[Ovid Therapeutics Inc, OVID] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 33.19% While, its Average True Range was 25.83.
Raw Stochastic average of Ovid Therapeutics Inc (OVID) in the period of the previous 100 days is set at 52.94%, which indicates a major rise in contrast to 3.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1077 that was lower than 0.1101 volatility it exhibited in the past 100-days period.
